Economic and Social Burden of Pulmonary Arterial Hypertension in Italy: A Cost-of-Illness Study
PAH has a substantial economic burden, increasing with disease severity. Early diagnosis and targeted interventions could improve patient outcomes, reduce complications, and optimize resource allocation for the National Health Service and society.
Authors
- Paola Argiento (ORCID: https://orcid.org/0000-0002-4004-5137)
- Roberto Badagliacca (ORCID: https://orcid.org/0000-0002-7887-5961)
- Laura Scelsi (ORCID: https://orcid.org/0000-0001-9409-691X)
- Claudia Raineri (ORCID: https://orcid.org/0000-0001-9653-1516)
- Martina Paoletti (ORCID: https://orcid.org/0000-0002-2564-6698)
- Paolo Sciattella (ORCID: https://orcid.org/0000-0002-8364-1895)
- Stefano Ghio (ORCID: https://orcid.org/0000-0002-1858-1152)
- Michele D’Alto (ORCID: https://orcid.org/0000-0001-5729-1038)
- Carmine Dario Vizza (ORCID: https://orcid.org/0000-0002-3540-4983)
Institutions
- University of Rome Tor Vergata (IT)
- University of Campania "Luigi Vanvitelli" (IT)
- Policlinico Umberto I (IT)
- Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT)
- University of Campania "Luigi Vanvitelli" (IT)
- Ospedale Monaldi (IT)
- Policlinico San Matteo Fondazione (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Drugs - Real World Outcomes
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1007/s40801-025-00520-y
- Citations
- 1
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.52